Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

UK Could Benefit By Up To ÷£5.7bn Through International Tobacco Smuggling Agreement
At the start of the next round of international negotiations in Geneva (28 June-5 July) [1], ASH is releasing a major new report showing that if a protocol on tobacco smuggling were to be adopted, it could
generic viagra online
Society Launches Consultations On Regulation Of Conduct In Schools Of Pharmacy
Students and staff, among others in the profession, have the chance to make their views
News of the day
National Jewish Health And Ceragenix Announce Compound Shows Promise For Treating Potentially Lethal Viral Infections
Ceragenix Pharmaceuticals, Inc.("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, announced that researchers at National Jewish Health, led by Dr. Donald Y. Leung and Dr. Michael Howell, in collaboration with Dr. Paul B. Savage of Brigham Young University, have demonstrated in a series of in vitro experiments and preclinical animal testing that an investigational drug compound known as CSA-13 shows promise as a potential therapy to treat viral infections from the vaccinia virus. The research appears ahead of print in an advanced online publication of the Journal of Investigate Dermatology, the official journal of the Society for Investigative Dermatology. This work was funded by the National Institute of Allergy and Infectious Diseases Atopic Dermatitis Vaccinia Network.
Endocrinology

New Blood Glucose Meter Connects To Gaming Systems

A new blood glucose monitor, unveiled today, connects directly to Nintendo DST and Nintendo DST Lite gaming systems and was designed specifically for children with diabetes. The Didget meter aims to encourage children to build good blood glucose testing habits by awarding points that children can use to unlock new game levels and customise their gaming experience. A welcome innovation "For many people with Type 1 diabetes, particularly children, having to do finger prick testing and inject insulin several times a day is an unpleasant but vital part of good diabetes management," said Pav Kalsi, Care Advisor at Diabetes UK. "Diabetes is a serious condition and can lead to long-term complications such as heart disease, kidney failure and blindness if not effectively managed. "Any safe and effective innovation which could encourage children to develop good testing habits now and for the rest of their lives is welcomed." Didget is by Bayer Diabetes Care UK. Diabetes UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009